| pubmed-article:7606649 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7606649 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:7606649 | lifeskim:mentions | umls-concept:C0018595 | lld:lifeskim |
| pubmed-article:7606649 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:7606649 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:7606649 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:7606649 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:7606649 | pubmed:dateCreated | 1995-8-16 | lld:pubmed |
| pubmed-article:7606649 | pubmed:abstractText | Many cases of refractory hypertension cannot be attributed to specific identifiable factors. Haptoglobin polymorphism has been suggested as a candidate genetic marker in essential hypertension. The aim of this study was to investigate the distribution of haptoglobin types in patients with refractory hypertension. | lld:pubmed |
| pubmed-article:7606649 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7606649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7606649 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7606649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7606649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7606649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7606649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7606649 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7606649 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:7606649 | pubmed:issn | 1350-6277 | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:Leroux-RoelsG... | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:ClementD LDL | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:DelangheJ RJR | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:De BuyzereM... | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:DuprezD ADA | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:ClaeysL RLR | lld:pubmed |
| pubmed-article:7606649 | pubmed:author | pubmed-author:BergerB EBE | lld:pubmed |
| pubmed-article:7606649 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7606649 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:7606649 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7606649 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7606649 | pubmed:pagination | 131-6 | lld:pubmed |
| pubmed-article:7606649 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:meshHeading | pubmed-meshheading:7606649-... | lld:pubmed |
| pubmed-article:7606649 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7606649 | pubmed:articleTitle | Refractory hypertension is associated with the haptoglobin 2-2 phenotype. | lld:pubmed |
| pubmed-article:7606649 | pubmed:affiliation | Department of Clinical Chemistry, University Hospital, Gent, Belgium. | lld:pubmed |
| pubmed-article:7606649 | pubmed:publicationType | Journal Article | lld:pubmed |
| entrez-gene:24464 | entrezgene:pubmed | pubmed-article:7606649 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7606649 | lld:pubmed |
